In 2019, it was estimated that around 8.5 percent of deaths worldwide could be attributed to obesity. The countries with the highest share of deaths that could be attributed to obesity included Fiji, the Cook Islands, and the United Arab Emirates. This statistic shows the countries with the highest share of deaths attributable to obesity worldwide in 2019.

In 2022, over ** percent of both men and women in the United States reported themselves as obese (BMI over 30), making it the country with the highest percentage of obese adults on this list. Other selected countries on the list with a high prevalence of obesity among adults included the United Kingdom and Australia. Obesity groups in the United States In 2023, Black adults had the highest overweight and obesity rates of any race or ethnicity in the United States. Asians and Native Hawaiians or Pacific Islanders had the lowest rates by far, with roughly ** percent. In 2022, almost ** percent of people aged 65 and older were obese in the United States. This estimate has been steadily increasing since 2013 when roughly ** percent of elderly Americans were obese. Leading health problems worldwide Obesity was considered one of 2024’s biggest health problems: ** percent of adults worldwide stated that obesity was the biggest health issue for people within their country. Around ** percent of adults stated that mental health was the most significant problem facing their country that year.

West Virginia, Mississippi, and Arkansas are the U.S. states with the highest percentage of their population who are obese. The states with the lowest percentage of their population who are obese include Colorado, Hawaii, and Massachusetts. Obesity in the United States Obesity is a growing problem in many countries around the world, but the United States has the highest rate of obesity among all OECD countries. The prevalence of obesity in the United States has risen steadily over the previous two decades, with no signs of declining. Obesity in the U.S. is more common among women than men, and overweight and obesity rates are higher among African Americans than any other race or ethnicity. Causes and health impacts Obesity is most commonly the result of a combination of poor diet, overeating, physical inactivity, and a genetic susceptibility. Obesity is associated with various negative health impacts, including an increased risk of cardiovascular diseases, certain types of cancer, and diabetes type 2. As of 2022, around 8.4 percent of the U.S. population had been diagnosed with diabetes. Diabetes is currently the eighth leading cause of death in the United States.

Thailand TH: Prevalence of Overweight: Weight for Height: % of Children Under 5 data was reported at 8.200 % in 2016. This records a decrease from the previous number of 10.900 % for 2012. Thailand TH: Prevalence of Overweight: Weight for Height: % of Children Under 5 data is updated yearly, averaging 8.000 % from Dec 1987 (Median) to 2016, with 5 observations. The data reached an all-time high of 10.900 % in 2012 and a record low of 1.300 % in 1987. Thailand TH: Prevalence of Overweight: Weight for Height: % of Children Under 5 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Thailand – Table TH.World Bank.WDI: Health Statistics. Prevalence of overweight children is the percentage of children under age 5 whose weight for height is more than two standard deviations above the median for the international reference population of the corresponding age as established by the WHO's new child growth standards released in 2006.; ; UNICEF, WHO, World Bank: Joint child malnutrition estimates (JME). Aggregation is based on UNICEF, WHO, and the World Bank harmonized dataset (adjusted, comparable data) and methodology.; Linear mixed-effect model estimates; Estimates of overweight children are also from national survey data. Once considered only a high-income economy problem, overweight children have become a growing concern in developing countries. Research shows an association between childhood obesity and a high prevalence of diabetes, respiratory disease, high blood pressure, and psychosocial and orthopedic disorders (de Onis and Blössner 2003). Childhood obesity is associated with a higher chance of obesity, premature death, and disability in adulthood. In addition to increased future risks, obese children experience breathing difficulties and increased risk of fractures, hypertension, early markers of cardiovascular disease, insulin resistance, and psychological effects. Children in low- and middle-income countries are more vulnerable to inadequate nutrition before birth and in infancy and early childhood. Many of these children are exposed to high-fat, high-sugar, high-salt, calorie-dense, micronutrient-poor foods, which tend be lower in cost than more nutritious foods. These dietary patterns, in conjunction with low levels of physical activity, result in sharp increases in childhood obesity, while under-nutrition continues

According to Cognitive Market Research, the global Obesity Intervention Devices market size will be USD 256.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.00% from 2024 to 2031.

North America held the major market share for more than 40% of the global revenue with a market size of USD 102.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 76.86 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 58.93 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 12.81 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 5.12 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031.
The Gastric Bands Device held the highest Obesity Intervention Devices market revenue share in 2024.

Market Dynamics of Obesity Intervention Devices Market

Key Drivers for Obesity Intervention Devices Market

Rising Obesity Rates to Increase the Demand Globally

Rising obesity rates are driving the obesity intervention devices market due to the increasing need for effective management and treatment solutions. As obesity rates escalate globally, more individuals require medical devices designed to aid in weight loss and management. This growing demand prompts healthcare providers and patients to seek advanced intervention options, such as surgical devices, non-surgical tools, and monitoring systems. The escalating prevalence of obesity-related health conditions, such as diabetes and cardiovascular diseases, further accelerates the need for these devices. In response, the market is expanding to offer innovative solutions that address the urgent need for effective obesity management, supporting the growth of the obesity intervention devices sector.

Growing awareness of obesity-related health risks to Propel Market Growth

Growing awareness of obesity-related health risks is driving the obesity intervention devices market as individuals and healthcare professionals increasingly recognize the serious health implications of obesity. This heightened awareness highlights the need for effective interventions to manage and reduce obesity, leading to a surge in demand for medical devices designed for weight management. As public awareness campaigns, educational programs, and media coverage shed light on the risks associated with obesity—such as diabetes, heart disease, and hypertension—more people are motivated to seek solutions. Consequently, healthcare providers are more likely to recommend advanced obesity intervention devices. This increased focus on prevention and treatment drives the growth of the market, fostering innovation and expanding the range of available obesity management solutions.

Restraint Factor for the Obesity Intervention Devices Market

High Initial Costs to Limit the Sales

High initial costs are restraining the obesity intervention devices market because the substantial investment required for advanced medical devices can limit their accessibility and adoption. These devices often involve complex technology and manufacturing processes, leading to elevated prices. For many patients and healthcare providers, the high cost poses a barrier, particularly in regions with limited healthcare budgets or insurance coverage. This financial constraint can delay or prevent the acquisition and use of such devices, impacting market growth. Additionally, high costs can lead to limited market penetration, especially in low- and middle-income countries where affordability is a significant issue. As a result, the high initial costs of obesity intervention devices can significantly restrict market expansion and adoption.

Impact of Covid-19 on the Obesity Intervention Devices Market

The COVID-19 pandemic impacted the obesity intervention devices market by disrupting supply chains and delaying elective procedures, including those related to obesity treatment. Lockdowns and social distancing measures led to reduced patient visits a...

Approximately *** percent of adolescents (10-19 years old) worldwide were obese in the year 2016, up from *** percent in 2000. The statistic illustrates the percentage of people worldwide who were overweight and obese in 2000 and 2016, by age.

This dataset shows the levels of overweight and obese people by country. Data is provided for 2002 and 2010 as a percentage of the total population and is also broken down by sex. Rates of change between 2002 and 2010 are also provided. The data was collated by the World Health Organisation (WHO)(http://www.who.int/gho/ncd/risk_factors/overweight/en/index.html) and was downloaded via the Guardian website (http://www.theguardian.com/news/datablog/interactive/2013/feb/19/obesity-map-of-world-weight). GIS vector data. This dataset was first accessioned in the EDINA ShareGeo Open repository on 2014-01-03 and migrated to Edinburgh DataShare on 2017-02-22.

Analysis of ‘🧑 Childhood Obesity in the US’ provided by Analyst-2 (analyst-2.ai), based on source dataset retrieved from https://www.kaggle.com/yamqwe/childhood-obesity-in-the-use on 13 February 2022.

--- Dataset description provided by original source is as follows ---

About this dataset

Childhood Obesity in the United States (1971-2014)

data source: http://www.cdc.gov/nchs/data/hestat/obesity_child_13_14/obesity_child_13_14.htm

Data Files

1. child_ob_gender.csv
2. obesity_child_age

Visualizations

Historical Childhood Obesity Rate by Gender

Boys tended to suffer from obesity at a higher rate than girls during 2000 through 2010. More recently however, between 2011 and 2014, boys' and girls' obesity rates converged as a result of an increase for girls and decrease for boys.

For both genders, obesity rates grew rapidly during the last two decades of the 20th century, but thankfully growth rates have lessened in recent years.

http://i.imgur.com/oyWAjys.png" alt="Imgur" style="">

Historical Childhood Obesity Rate by Age

The data show that older children have been afflicted by the obesity epidemic at a higher rate than very young children.

http://i.imgur.com/7W2Bsz3.png" alt="Imgur" style="">

This dataset was created by Health and contains around 100 samples along with Se, Percent Obese, technical information and other features such as: - Gender - Time - and more.

How to use this dataset

• Analyze Age in relation to Se
• Study the influence of Percent Obese on Gender
• More datasets

Acknowledgements

If you use this dataset in your research, please credit Health

Start A New Notebook!

--- Original source retains full ownership of the source dataset ---

Mali ML: Prevalence of Overweight: Weight for Height: % of Children Under 5 data was reported at 1.900 % in 2015. This records an increase from the previous number of 1.000 % for 2010. Mali ML: Prevalence of Overweight: Weight for Height: % of Children Under 5 data is updated yearly, averaging 2.100 % from Dec 1987 (Median) to 2015, with 6 observations. The data reached an all-time high of 4.700 % in 2006 and a record low of 0.500 % in 1987. Mali ML: Prevalence of Overweight: Weight for Height: % of Children Under 5 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Mali – Table ML.World Bank: Health Statistics. Prevalence of overweight children is the percentage of children under age 5 whose weight for height is more than two standard deviations above the median for the international reference population of the corresponding age as established by the WHO's new child growth standards released in 2006.; ; UNICEF, WHO, World Bank: Joint child malnutrition estimates (JME). Aggregation is based on UNICEF, WHO, and the World Bank harmonized dataset (adjusted, comparable data) and methodology.; Linear mixed-effect model estimates; Estimates of overweight children are also from national survey data. Once considered only a high-income economy problem, overweight children have become a growing concern in developing countries. Research shows an association between childhood obesity and a high prevalence of diabetes, respiratory disease, high blood pressure, and psychosocial and orthopedic disorders (de Onis and Blössner 2003). Childhood obesity is associated with a higher chance of obesity, premature death, and disability in adulthood. In addition to increased future risks, obese children experience breathing difficulties and increased risk of fractures, hypertension, early markers of cardiovascular disease, insulin resistance, and psychological effects. Children in low- and middle-income countries are more vulnerable to inadequate nutrition before birth and in infancy and early childhood. Many of these children are exposed to high-fat, high-sugar, high-salt, calorie-dense, micronutrient-poor foods, which tend be lower in cost than more nutritious foods. These dietary patterns, in conjunction with low levels of physical activity, result in sharp increases in childhood obesity, while under-nutrition continues

Panama PA: Prevalence of Overweight: Weight for Height: % of Children Under 5, Modeled Estimate data was reported at 10.900 % in 2024. This records a decrease from the previous number of 11.100 % for 2023. Panama PA: Prevalence of Overweight: Weight for Height: % of Children Under 5, Modeled Estimate data is updated yearly, averaging 10.900 % from Dec 2000 (Median) to 2024, with 25 observations. The data reached an all-time high of 11.500 % in 2019 and a record low of 8.300 % in 2000. Panama PA: Prevalence of Overweight: Weight for Height: % of Children Under 5, Modeled Estimate data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Panama – Table PA.World Bank.WDI: Social: Health Statistics. Prevalence of overweight children is the percentage of children under age 5 whose weight for height is more than two standard deviations above the median for the international reference population of the corresponding age as established by the WHO's 2006 Child Growth Standards.;UNICEF, WHO, World Bank: Joint child Malnutrition Estimates (JME).;Weighted average;Once considered only a high-income economy problem, overweight children have become a growing concern in developing countries. Research shows an association between childhood obesity and a high prevalence of diabetes, respiratory disease, high blood pressure, and psychosocial and orthopedic disorders (de Onis and Blössner 2003). Childhood obesity is associated with a higher chance of obesity, premature death, and disability in adulthood. In addition to increased future risks, obese children experience breathing difficulties and increased risk of fractures, hypertension, early markers of cardiovascular disease, insulin resistance, and psychological effects. Children in low- and middle-income countries are more vulnerable to inadequate nutrition before birth and in infancy and early childhood. Many of these children are exposed to high-fat, high-sugar, high-salt, calorie-dense, micronutrient-poor foods, which tend be lower in cost than more nutritious foods. These dietary patterns, in conjunction with low levels of physical activity, result in sharp increases in childhood obesity, while under-nutrition continues. Estimates are modeled estimates produced by the JME. Primary data sources of the anthropometric measurements are national surveys. These surveys are administered sporadically, resulting in sparse data for many countries. Furthermore, the trend of the indicators over time is usually not a straight line and varies by country. Tracking the current level and progress of indicators helps determine if countries are on track to meet certain thresholds, such as those indicated in the SDGs. Thus the JME developed statistical models and produced the modeled estimates.

In 2021, around 16 percent of deaths in Bahrain were attributed to obesity, while around nine percent of deaths in the United States were attributed to obesity. This statistic shows the percentage of deaths in select countries worldwide that were attributed to obesity in 2021.

Introduction

Weight Loss Statistics: In 2024, weight loss remains a prominent concern worldwide, driven by rising obesity rates and an increased focus on health and wellness. As more people become aware of the health risks associated with being overweight, the demand for effective weight loss solutions continues to grow.

This report explores the latest weight loss statistics, highlighting key trends, popular methods, and the economic impact of the industry. With a global market value projected to surpass almost USD 300 billion this year, the weight loss industry is not only a reflection of changing lifestyle choices but also a significant contributor to the global economy.

In 2020, around 42 percent of adults aged 20 years and older worldwide were considered overweight or obese. This statistic shows the percentage of adults aged 20 years and older who were overweight or obese worldwide in 2020 and forecasts for the years 2025, 2030, and 2035.

Obesity Intervention Devices Market Outlook

The global market size for obesity intervention devices was valued at approximately USD 1.4 billion in 2023, and it is expected to reach around USD 3.2 billion by 2032, growing at a CAGR of 9.5% during the forecast period. This robust growth is driven by increasing obesity rates worldwide, advancements in medical technology, and rising awareness regarding the health risks associated with obesity.

One of the key growth factors for the obesity intervention devices market is the alarming increase in obesity rates across the globe. According to the World Health Organization (WHO), the global obesity rate has nearly tripled since 1975, with over 650 million adults classified as obese in 2020. This rising prevalence of obesity has heightened the need for effective intervention strategies, thereby driving the demand for obesity intervention devices. Furthermore, obesity is a significant risk factor for various chronic diseases such as diabetes, cardiovascular diseases, and certain cancers, which makes the management of obesity a critical public health priority.

Technological advancements in the field of medical devices have also played a crucial role in propelling the growth of the obesity intervention devices market. Innovations such as minimally invasive surgical techniques, improved biocompatible materials, and the development of more effective and safer obesity intervention devices have significantly enhanced patient outcomes and reduced recovery times. These advancements have increased the adoption of obesity intervention devices among healthcare providers and patients alike, further fueling market growth.

Another important growth factor is the increasing awareness and acceptance of obesity intervention procedures among the general population. With more information available through various channels, including social media, healthcare campaigns, and educational programs, patients are becoming more informed about the benefits and availability of obesity intervention devices. This growing awareness, coupled with favorable reimbursement policies in many regions, has led to an increase in the number of patients seeking obesity intervention treatments, thereby driving market expansion.

Bariatric (Obesity) Surgical Devices have emerged as a pivotal component in the arsenal against obesity, offering patients a range of surgical options to achieve significant weight loss. These devices are designed to either restrict food intake or alter the digestive process, thereby facilitating weight reduction. The development of advanced bariatric surgical devices has been instrumental in improving the safety and efficacy of weight loss surgeries. With the increasing prevalence of obesity, there is a growing demand for these devices, as they provide a viable solution for patients who have not achieved desired results through conventional weight loss methods. The integration of cutting-edge technology in bariatric surgical devices has enhanced patient outcomes, reduced recovery times, and minimized complications, making them a preferred choice among healthcare providers and patients alike.

Regionally, North America holds a significant share of the obesity intervention devices market, driven by high obesity rates, advanced healthcare infrastructure, and strong market presence of key manufacturers. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period, primarily due to the rising prevalence of obesity, increasing healthcare expenditure, and growing awareness about obesity-related health risks. Europe also represents a substantial market share, supported by well-established healthcare systems and favorable government policies promoting obesity management interventions.

Product Type Analysis

The product type segment of the obesity intervention devices market is categorized into gastric bands, gastric balloons, gastric electrical stimulation devices, gastric emptying systems, and others. Gastric bands, also known as laparoscopic adjustable gastric bands, are among the most widely used devices due to their efficacy in reducing stomach size and limiting food intake. These bands are adjustable and reversible, making them a preferred choice for many patients and healthcare providers. The ease of implantation and lower complication rates further contribute to the popularity of gastric bands in the obesity intervention devices market.

Obesity Intervention Devices Market size was valued at USD 267.88 Million in 2024 and is projected to reach USD 417.08 Million by 2031, growing at a CAGR of 5.69% during the forecast period 2024-2031.

Global Obesity Intervention Devices Market Drivers

The market drivers for the Obesity Intervention Devices Market can be influenced by various factors. These may include:

Growing Obesity Rates: Due to changes in nutrition, lifestyle, and physical activity levels, obesity rates have been rising globally throughout time. As a result, there is an increasing need for therapies that deal with health problems associated with obesity. Enhanced Knowledge and Education: As people become more conscious of the health hazards linked to obesity, there is a greater need for efficient solutions. This awareness is further fueled by educational programs and public health campaigns. Technological Developments: Wearables, implantable devices, and minimally invasive surgery are just a few of the novel obesity intervention devices that have been made possible by advances in medical technology. These developments draw in patients looking for practical answers as well as healthcare professionals. Government Policies and Initiatives: By fostering an environment that is conducive to the adoption of obesity intervention devices, government policies and initiatives, such as taxes on sugar-filled beverages, subsidies for healthful foods, and physical activity-promoting regulations, can help drive demand for these devices. Healthcare Cost Burden: Health problems associated with obesity place a heavy financial strain on healthcare systems around the globe. Consequently, there is an increasing emphasis on interventions and preventive strategies to lower healthcare expenses connected to illnesses related to obesity. This justifies the purchase of obesity intervention technology as an affordable fix. Growing Healthcare Expenditure: Consumers and healthcare providers are eager to invest in cutting-edge therapies and equipment for managing obesity, as seen by the general increase in healthcare spending around the world. Changing Demographics: The incidence of obesity and associated health problems is influenced by aging populations and shifting demographics, especially in wealthy nations. The need for obesity intervention tools that can specifically cater to the needs of senior populations is being driven by this shift in demographics. Lifestyle Changes: The obesity epidemic is partly caused by urbanization, sedentary lifestyles, and changes in food habits. Obesity intervention devices are appealing choices for people looking for efficient weight-management techniques since they provide answers that fit with contemporary lifestyles. Growing Interest in Personalized Medicine: Thanks to developments in precision medicine and genetics, there is a growing movement in personalized healthcare. Customized obesity prevention tools that consider personal characteristics like genetics, metabolism, and behavior are becoming more and more popular. Partnerships and Collaborations: The development of comprehensive obesity management solutions, including intervention devices, is fueled by partnerships and collaborations among healthcare providers, pharmaceutical companies, research institutes, and makers of medical devices. These collaborations support the field's efforts in R&D and commercialization.

Obesity Treatment Devices Market Outlook

The global obesity treatment devices market size was valued at approximately USD 1.8 billion in 2023 and is projected to reach around USD 4.1 billion by 2032, growing at a robust CAGR of 9.4% during the forecast period. The increasing prevalence of obesity worldwide, coupled with advancements in medical technology and a growing awareness regarding the health risks associated with obesity, are key driving factors contributing to the market growth. Additionally, the increasing acceptance and adoption of minimally invasive procedures for weight loss are further propelling the market expansion.

One of the critical growth drivers for the obesity treatment devices market is the rising obesity rates across the globe. According to the World Health Organization (WHO), obesity has nearly tripled since 1975, with over 650 million adults classified as obese in 2016. This alarming rise is primarily attributed to sedentary lifestyles, unhealthy diets, and genetic factors. The increasing obesity prevalence is pushing healthcare systems and governments to invest heavily in obesity management and treatment solutions, thereby fueling the demand for obesity treatment devices.

Technological advancements in obesity treatment devices are also significant contributors to market growth. Innovations such as adjustable gastric bands, minimally invasive gastric balloons, and advanced electrical stimulation systems offer effective, less invasive, and safer alternatives to traditional bariatric surgery. These advancements have improved patient outcomes, reduced recovery times, and minimized complications, making them more appealing to both patients and healthcare providers. Consequently, the adoption of these advanced devices is expected to witness substantial growth in the coming years.

Public awareness and government initiatives aimed at combating obesity are further enhancing the market outlook. Various health organizations and government bodies are launching campaigns and programs to educate people about the health risks of obesity and the available treatment options. These initiatives not only promote healthier lifestyles but also encourage individuals to seek medical interventions, thereby driving the demand for obesity treatment devices. Additionally, favorable reimbursement policies and increasing healthcare expenditure in developed and developing regions are expected to boost market growth.

From a regional perspective, North America currently holds the largest market share in the obesity treatment devices market, followed by Europe and Asia Pacific. The high obesity rates, advanced healthcare infrastructure, and strong presence of key market players in North America are key factors contributing to its dominance. Meanwhile, the Asia Pacific region is anticipated to witness the highest growth rate during the forecast period, driven by the increasing prevalence of obesity, rising healthcare expenditure, and growing awareness about obesity treatment options.

Product Type Analysis

The obesity treatment devices market is segmented into various product types, including gastric bands, gastric balloons, electrical stimulation systems, gastric emptying systems, and others. Gastric bands are among the most commonly used devices, particularly due to their adjustability and reversibility. These bands are placed around the upper part of the stomach, creating a small pouch that limits food intake and promotes a feeling of fullness. The simplicity and effectiveness of gastric bands have made them a popular choice among both patients and healthcare providers.

Gastric balloons, another significant segment, are gaining traction due to their minimally invasive nature. These devices are inserted into the stomach via endoscopy and filled with saline to occupy space, thereby reducing hunger and promoting weight loss. Gastric balloons are typically used for short-term weight loss and are removed after six months. Their temporary nature and low risk of complications have made them an attractive option for patients seeking non-surgical weight loss solutions.

Electrical stimulation systems are innovative devices that stimulate the vagus nerve to control hunger signals and promote weight loss. These systems are implanted surgically and have shown promising results in clinical trials. The ability to modulate appetite without altering the digestive system

Introduction: Severe obesity among children and adolescents has emerged as a public health concern in multiple places around the world. Methods: We searched the Medline database for articles on severe obesity rates in children published between January 1960 and January 2020. For studies with available prevalence rates for an early and a more recent time period, the relative increase in prevalence was imputed.
Results: In total, 874 publications were identified, of which 38 contained relevant epidemiological data. Rates of severe obesity varied significantly according to age, gender, geographic area, and the definition of severe obesity. The highest rates of class II and III obesity in the US according to the Centers of Disease Control cutoff were 9.5% and 4.5%, respectively. Seventeen studies reported prevalence rates in at least two time periods. Data for 9,190,718 individuals showed a 1.71 (95%CI, 1.53-1.90) greater odds for severe obesity in 2006-2017 (N=5,029,584) vs. 1967-2007 (N=4,161,134). In an analysis limited to studies from 1980s’ with a minimum follow-up of 20 years, a 9.16(95%CI, 7.76-10.80) greater odds for severe obesity in recent vs. earlier time was found. An analysis limited to studies from 2000, with a follow-up of 5-15 years, a 1.09 (95%CI, 0.99-1.20) greater odds was noted when comparing (2011-2017; N=4,991,831) vs. (2000-2011; N=4,134,340). Conclusion: Severe pediatric obesity is escalating with a marked increase from the1980’s and a slower rate from 2000.

Weight Loss and Obesity Management Market Outlook

The global weight loss and obesity management market size was valued at approximately USD 175 billion in 2023 and is projected to reach USD 350 billion by 2032, growing at a compound annual growth rate (CAGR) of about 7.8% during the forecast period. This remarkable growth is driven by increasing health consciousness, rising obesity rates, and technological advancements in weight management solutions. The growing prevalence of obesity, coupled with the increasing awareness regarding the health risks associated with being overweight, has significantly propelled the demand for effective weight management products and services on a global scale. The availability of a variety of weight management programs, from dietary supplements to surgical interventions, further fuels market growth.

One of the primary growth factors in the weight loss and obesity management market is the rising incidence of obesity across various age groups around the world. The World Health Organization has frequently cited obesity as one of the most significant health challenges of the 21st century, affecting people in both developed and developing countries. This has led to an increased focus on preventive healthcare measures, thereby boosting demand for products and services that aid in weight management. Additionally, the growing influence of social media and the internet has made it easier for people to access information about healthy lifestyles, creating a more health-conscious global population eager to invest in weight management solutions.

Technological advancements have also played a crucial role in propelling the weight loss and obesity management market. The integration of technology in fitness and dietary products has made weight management more accessible and efficient. Innovations such as wearable fitness trackers, mobile health applications, and smart scales have enabled individuals to monitor their fitness progress in real-time, offering a personalized approach to managing weight. Furthermore, advancements in medical procedures, such as non-invasive bariatric surgeries, have expanded the options available to individuals seeking professional medical aid for weight loss, thereby contributing to the marketÂ’s growth.

Another significant growth factor is the increasing governmental and private sector initiatives aimed at combating the obesity epidemic. Many governments have developed national strategies and policies to promote healthy lifestyles and prevent obesity-related health complications. These initiatives often include public awareness campaigns, subsidies for fitness centers, and the implementation of stringent regulations on unhealthy food products. Moreover, private companies are investing heavily in research and development to create innovative weight loss solutions that are safe, effective, and accessible to a broader audience. These combined efforts are anticipated to create robust growth opportunities in the weight loss and obesity management market over the forecast period.

In the context of Slimming Weight Management, the market has seen a surge in demand for personalized and holistic approaches to weight loss. Consumers are increasingly seeking solutions that not only focus on shedding pounds but also promote overall wellness and sustainable lifestyle changes. Slimming centers, in particular, have capitalized on this trend by offering comprehensive programs that combine dietary guidance, physical activity, and behavioral therapy. These centers emphasize the importance of a balanced approach, recognizing that effective weight management is not just about quick fixes but about long-term health benefits. The integration of modern technologies, such as body composition analysis and metabolic rate assessments, has further enhanced the efficacy of these programs, making them a popular choice among health-conscious individuals.

The regional outlook for the weight loss and obesity management market indicates that North America is expected to maintain its dominance, owing to the high prevalence of obesity and the presence of advanced healthcare infrastructure. The Asia Pacific region, however, is projected to witness the highest growth rate due to the rapidly increasing obesity rates in countries like India and China, coupled with rising disposable incomes and growing awareness about health and fitness. Europe is also expected to experience substantial growth, driven by supportive government policies and an increasing number of fitness enthusiasts. The Middle East & Africa

The size of the Obesity Treatment Market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 15.00% during the forecast period. The world obesity treatment market is growing rapidly with the increasing rates of obesity around the world. Obesity treatment may be defined as the medical interventions aimed at reducing excess body weights and improving general health. This ranges from lifestyle modifications, medications, and surgical procedures among various others. Many treatments begin with lifestyle changes, which include dietary modifications, physical activity, and behavioral therapy. They discuss the establishment of healthy practices that contribute to weight loss enhancement and proper weight. Weight loss drugs are classified into three: appetite suppressors, lipase inhibitors, and glucagon-like peptide-1 (GLP-1) agonists. This is designed for patients who cannot change their lifestyle. For those who are not only obese but also overweight, surgical treatment is an alternative. This aims at either reducing the size of the stomach or bypassing the digestive tract. Indeed, selection of treatment is different and depends on such factors as body mass, the overall status of health, and personal preferences; as such, the treatment of obesity is actually a drug intended for improvement of physical and psychic well-being and prevention of lifestyle and chronic diseases and improvement of quality of life. Recent developments include: June 2021: the United States Food and Drug Administration (FDA) approved Semaglutide 2.4 mg for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure or cholesterol, or T2D) for use in addition to a reduced-calorie diet and increased physical activity., January 2021: Novo Nordisk AS signed a partnership with the startup Fauna Bio to identify new therapeutic approaches to obesity by studying the molecules and pathways that regulate metabolism in hibernating animals.. Key drivers for this market are: Increasing Burden of Obesity and Related Chronic Diseases, Growing Unhealthy and Sedentary Lifestyles. Potential restraints include: Availability of Alternative Treatment Options, Side Effects of Drugs. Notable trends are: The Prescription Drugs Segment is Expected to Exhibit a Faster Growth Rate Over the Forecast Period.

Kuwait KW: Prevalence of Overweight: Weight for Height: % of Children Under 5, Modeled Estimate data was reported at 10.100 % in 2024. This records an increase from the previous number of 10.000 % for 2023. Kuwait KW: Prevalence of Overweight: Weight for Height: % of Children Under 5, Modeled Estimate data is updated yearly, averaging 8.800 % from Dec 2000 (Median) to 2024, with 25 observations. The data reached an all-time high of 10.100 % in 2024 and a record low of 7.800 % in 2000. Kuwait KW: Prevalence of Overweight: Weight for Height: % of Children Under 5, Modeled Estimate data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Kuwait – Table KW.World Bank.WDI: Social: Health Statistics. Prevalence of overweight children is the percentage of children under age 5 whose weight for height is more than two standard deviations above the median for the international reference population of the corresponding age as established by the WHO's 2006 Child Growth Standards.;UNICEF, WHO, World Bank: Joint child Malnutrition Estimates (JME).;Weighted average;Once considered only a high-income economy problem, overweight children have become a growing concern in developing countries. Research shows an association between childhood obesity and a high prevalence of diabetes, respiratory disease, high blood pressure, and psychosocial and orthopedic disorders (de Onis and Blössner 2003). Childhood obesity is associated with a higher chance of obesity, premature death, and disability in adulthood. In addition to increased future risks, obese children experience breathing difficulties and increased risk of fractures, hypertension, early markers of cardiovascular disease, insulin resistance, and psychological effects. Children in low- and middle-income countries are more vulnerable to inadequate nutrition before birth and in infancy and early childhood. Many of these children are exposed to high-fat, high-sugar, high-salt, calorie-dense, micronutrient-poor foods, which tend be lower in cost than more nutritious foods. These dietary patterns, in conjunction with low levels of physical activity, result in sharp increases in childhood obesity, while under-nutrition continues. Estimates are modeled estimates produced by the JME. Primary data sources of the anthropometric measurements are national surveys. These surveys are administered sporadically, resulting in sparse data for many countries. Furthermore, the trend of the indicators over time is usually not a straight line and varies by country. Tracking the current level and progress of indicators helps determine if countries are on track to meet certain thresholds, such as those indicated in the SDGs. Thus the JME developed statistical models and produced the modeled estimates.